Maternal vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids.
BACKGROUND
Vitamin A supplementation is believed to enhance immune responses to infection but few studies have assessed its effects on anti-malarial immunity, especially during pregnancy when women are at increased risk from both vitamin A deficiency and pregnancy-associated malaria. The pathological effects of malaria in pregnancy are believed to be due to the sequestration of parasites in the placenta mediated via binding of variant surface antigens (VSA) expressed on the surface of P. falciparum infected red blood cells to placental chondroitin sulphate A (CSA).


METHODS
We conducted a randomized double-blind controlled trial of vitamin A supplementation in 98 primigravid Ghanaian women to investigate the effects of vitamin A supplementation on levels of IgG antibodies binding to VSA of a clinical, P. falciparum placental isolate and to two isolates selected (or not) for adherence to CSA in vitro (anti-VSACSA IgG or anti-VSA IgG). Placental malarial infection was determined by placental blood smear and histology.


RESULTS
Vitamin A supplementation was non-significantly associated with a decreased risk of active or chronic-active placental malarial infection compared to past, resolved infection at delivery, as determined by histology (OR=0.42, P=0.13--adjusted for level of education). After adjustment for differences in baseline values, levels of anti-VSACSA IgG to a placental, CSA-adherent isolate (EJ-24) but not to two isolates selected for CSA-adhesion in vitro (FCR3CSA and BusuaCSA), were significantly lower in women receiving vitamin A supplementation than in women receiving placebo (P=0.002). There was no apparent effect of vitamin A supplementation to levels of Ab to non-CSA-adherent parasite isolates.


CONCLUSIONS
The data suggest that the reduction in the levels of anti-VSACSA antibodies to the known placental malaria isolate may reflect reduced intensity or duration of placental parasitaemia in women receiving vitamin A supplementation. These observations are of potential public health significance and deserve further investigation.
Cox
Sharon E
SE
Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. Sharon.Cox@lshtm.ac.uk
Staalsoe
Trine
T
Arthur
Paul
P
Bulmer
Judith N
JN
Tagbor
Harry
H
Hviid
Lars
L
Frost
Chris
C
Riley
Eleanor M
EM
Kirkwood
Betty R
BR
D000328:Adult; D000740:Anemia / Q000453:epidemiology / Q000276:immunology; D000913:Antibodies, Protozoan / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D002809:Chondroitin Sulfates / Q000276:immunology; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D005869:Ghana / Q000453:epidemiology; D020073:Gravidity; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D016778:Malaria, Falciparum / Q000276:immunology*; D010922:Placenta Diseases / Q000276:immunology; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000276:immunology*; D012307:Risk Factors; D014801:Vitamin A / Q000008:administration & dosage*; D014802:Vitamin A Deficiency / Q000178:diet therapy / Q000276:immunology
D000913:Antibodies, Protozoan; D000954:Antigens, Surface; D007074:Immunoglobulin G; D014801:Vitamin A; D002809:Chondroitin Sulfates